• Guest - w'd love to know what you think about the forum! Take the 2025 Survey »

Freestyle Libre 2 to become real time continuous glucose monitor in UK from mid July 2023

B

BadaBing

Well-Known Member
Messages
100
Type of diabetes
Type 1
Treatment type
Insulin
Someone has posted on Facebook this morning that from mid-july 2023, and following a software update to Librelink, the Freestyle Libre 2 sensor will become a real time continuous glucose monitor in the United Kingdom, giving minute-by-minute readings on a compatible smartphone.

Apparently, the updated Librelink will also allow glucose readings to be sent to compatible smartwatches (presumably without the need to use non-Abbott authorised third party apps).

Abbott should be communicating this to UK Libre 2 users over coming weeks.
 
Last edited:
If this is true, things could become very interesting in the Netherlands.

Around here, Libre2 is available for all on multiple daily injections or a pump, but Libre 3 and other true CGMs are only funded for those who fall within very specific conditions.
With this software update all of us on Libre2 would suddenly not be eligible for funding anymore. Which would be too ridiculous a conclusion even for our government to make.

So if this is indeed true, this may lead to us being eligible for all CGMs, because the difference in funding is based on Libre2 being a flash monitor and not a true CGM.
Very curious as to how this will play out. :hilarious:
 
Antje77 said:
If this is true, things could become very interesting in the Netherlands.

Around here, Libre2 is available for all on multiple daily injections or a pump, but Libre 3 and other true CGMs are only funded for those who fall within very specific conditions.
With this software update all of us on Libre2 would suddenly not be eligible for funding anymore. Which would be too ridiculous a conclusion even for our government to make.

So if this is indeed true, this may lead to us being eligible for all CGMs, because the difference in funding is based on Libre2 being a flash monitor and not a true CGM.
Very curious as to how this will play out. :hilarious:
Click to expand...
@Antje77 I will be interested to hear how things play out in the Netherlands.

From a healthcare perspective, I would hope that your politicians and healthcare service would not allow any changes that might affect adversely the provision of care to diabetic patients or the cost to them of that care.

As a business, I imagine Abbott won't want to have many different variations of the same product trans-nationally because it increases costs at their end.
 
Back
Top